EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

NEWMARKET CORPORATION REPORTS IMPROVED SECOND QUARTER AND SIX MONTH 2004 RESULTS

 

  Formation of NewMarket Corporation completed

 

  Petroleum additives and TEL second quarter and six month results improve

 

  New loan agreement completed

 

Richmond, VA, July 29, 2004 –NewMarket Corporation (NYSE-NEU) President and Chief Executive Officer, Thomas E. Gottwald, released the following earnings report for the second quarter and six months 2004 and an update of the company’s operations.

 

Both petroleum additives and tetraethyl lead (TEL) earnings improved in the second quarter and first half of 2004 over the same periods last year. Earnings from continuing operations for the first half of 2004 improved significantly to $17.2 million, or $1.02 per share, compared to earnings on the same basis for the first half of last year of $5.6 million, or $.33 cents per share. First half net income in 2003, including the $14.8 million gain on the sale of our phenolic antioxidant business and a $1.6 million benefit upon adoption of Statement of Accounting Standards No. 143, amounted to $22 million or $1.32 per share. These 2003 items are included in the summary of earnings chart at the end of this earnings release. Net income for the second quarter of this year of $11.4 million, or $.67 per share, was also up significantly from second quarter 2003 net income of $5.7 million, or $.34 per share.

 

Petroleum additive profits improved 26% for the first half of 2004 and 20% for the second quarter compared with the same periods last year. These results include an increase in net sales of petroleum additives of 23% for the first half and 22% for the second quarter. This performance represents the best first-half petroleum additives earnings since 1999 and includes higher shipments in almost all of our major product lines. Raw material costs were higher in the 2004 periods. Research, development and testing costs were also higher for the first half of 2004 in support of our growth strategies, the requirements of new product specifications and our commitment to supply our customers with additives that help differentiate their products.

 

TEL earnings also improved for the second quarter and six months compared with the same periods last year. The improvement reflects higher pricing as well as an increase in shipments


compared to the same periods last year. TEL segment results are subject to significant quarterly swings and therefore we do not believe that quarter to quarter comparisons are particularly meaningful.

 

During the quarter, we also completed the restructuring of our term and bank loans with terms that we believe are more consistent with our improved financial position. This restructured facility consists of a $100 million revolving loan which we believe provides us more financial flexibility as we move forward.

 

While we are pleased with our first half performance, we expect the second half results to be lower than the first. We have been somewhat successful in raising the selling prices of our petroleum additives products. However, our current price improvements do not cover the increased raw material costs, as the price of oil-based raw materials remains at record high levels, thereby reducing margins. On TEL, we expect the full year 2004 results to be below last year. Given that the first half for TEL was stronger than the first half last year, we expect that the second half will be weaker.

 

The continuing improvement in earnings is a result of the dedication and efforts of employees of the family of NewMarket companies worldwide. We believe that the new holding company structure enables the management of our operating subsidiaries, Afton Chemical Corporation and Ethyl Corporation, to focus more intensely than ever on the challenges, opportunities and strategies for their respective product lines and markets.

 

Sincerely,

Thomas E. Gottwald

 

Please review our 10-Q filing for a more thorough discussion of the topics mentioned in this release.

 

Earnings for the six months 2003 included significant nonrecurring items. The following summary of earnings totaling net income under generally accepted accounting principles is included below as part of the earnings release.

 

2


Summary of earnings for the Second Quarter and Six Months:

 

    

Second Quarter Ended

June 30


  

Six Months Ended

June 30


     2004

   2003

   2004

   2003

Net income:

                           

Earnings excluding discontinued operations and nonrecurring item

   $ 11.4    $ 5.7    $ 17.2    $ 5.6

Discontinued operations (2003 gain on sale of phenolic antioxidant business) (1)

     —        —        —        14.8

Gain upon adoption of SFAS No. 143 (1)

     —        —        —        1.6
    

  

  

  

Net income

   $ 11.4    $ 5.7    $ 17.2    $ 22.0
    

  

  

  

Basic earnings per share: (2)

                           

Earnings excluding discontinued operations and nonrecurring item

   $ 0.67    $ 0.34    $ 1.02    $ 0.33

Discontinued operations (2003 gain on sale of phenolic antioxidant business) (1)

     —        —        —        0.89

Gain upon adoption of SFAS No. 143 (1)

     —        —        —        0.10
    

  

  

  

Net income

   $ 0.67    $ 0.34    $ 1.02    $ 1.32
    

  

  

  


(1) Details included in notes to accompanying financial statements.
(2) Information on diluted earnings per share is included in the accompanying Segment Results and Other Financial Information Statement.

 

As a reminder, a conference call and Internet web cast is scheduled for 10:00 a.m. EDT on July 30, 2004 to review second quarter 2004 financial results. You can access the conference call live by dialing 800-657-1269 (domestic) or 973-409-9259 (international) and requesting the NewMarket conference call. To avoid delays, callers should dial in five minutes early. The call will also be broadcast via the Internet and can be accessed through the Company’s website at www.NewMarket.com or www.vcall.com. A teleconference replay of the call will be available until 8-2-04 by dialing 877-519-4471 (domestic) and 973-341-3080 (international). The replay passcode is 4974751. A webcast replay will be available for 30 days.

 

NewMarket Corporation through its subsidiaries, Afton Chemical Corporation and Ethyl Corporation, develops, manufactures, blends, and delivers chemical additives that enhance the performance of petroleum products. From custom-formulated chemical blends to market-general additive components, the NewMarket family of companies provides the world with the technology to make fuels burn cleaner, engines run smoother and machines last longer.

 

Some of the information contained in this press release constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although NewMarket’s management believes its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that actual results will not differ materially from expectations.

 

3


Factors that could cause actual results to differ materially from expectations include, but are not limited to: timing of sales orders; gain or loss of significant customers; competition from other manufacturers; resolution of environmental liabilities; changes in the demand for our products; significant changes in new product introduction; increases in product cost; the impact of fluctuations in foreign exchange rates on reported results of operations; changes in various markets; geopolitical risks in certain of the countries in which we conduct business; the impact of consolidation of the petroleum additives industry; and other factors detailed from time to time in the reports that NewMarket files with the Securities and Exchange Commission, including the risk factors in Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” of our 2003 Annual Report on Form 10-K, which is available to shareholders upon request.

 

You should keep in mind that any forward-looking statement made by NewMarket in the foregoing discussion speaks only as of the date on which such forward-looking statement is made. New risks and uncertainties come up from time to time, and it is impossible for us to predict these events or how they may affect the company. We have no duty to, and do not intend to, update or revise the forward-looking statements in this discussion after the date hereof, except as may be required by law. In light of these risks and uncertainties, you should keep in mind that the events described in any forward-looking statement made in this discussion, or elsewhere, might not occur.

 

To the extent that this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. For management’s statement concerning the reasons why management believes that presentation of non-GAAP measures provides useful information to investors concerning NewMarket’s financial condition and results of operations, see the Form 8-K furnished to the Securities and Exchange Commission on July 29, 2004.

 

FOR INVESTOR INFORMATION CONTACT:

 

David A. Fiorenza

Investor Relations

Phone: 804.788.5555

Fax: 804.788.5688

Email: investorrelations@newmarket.com

 

4


NEWMARKET CORPORATION AND SUBSIDIARIES

SEGMENT RESULTS AND OTHER FINANCIAL INFORMATION

(In millions except per share amounts, unaudited)

 

     Second Quarter

    Six Months

 
     2004

    2003

    2004

    2003

 

Net sales:

                                

Petroleum additives

   $ 218.1     $ 178.8     $ 432.8     $ 350.6  

Tetraethyl lead

     3.4       1.8       5.5       3.4  
    


 


 


 


Total

   $ 221.5     $ 180.6     $ 438.3     $ 354.0  
    


 


 


 


Segment operating profit:

                                

Petroleum additives before nonrecurring item

   $ 19.3     $ 16.0     $ 34.2     $ 27.2  

Nonrecurring item (a)

     —         —         —         0.1  
    


 


 


 


Total petroleum additives

     19.3       16.0       34.2       27.3  

Tetraethyl lead

     10.1       6.4       17.4       7.8  

Nonrecurring item (a)

     —         —         —         2.4  
    


 


 


 


Total tetraethyl lead

     10.1       6.4       17.4       10.2  

Segment operating profit

     29.4       22.4       51.6       37.5  

Deduct nonrecurring item to reconcile

                                

Segment Reporting to Consolidated Statements of Income (b)

     —         —         —         (2.5 )

Corporate unallocated expense

     (5.4 )     (4.5 )     (10.7 )     (9.3 )

Interest expense

     (4.5 )     (6.4 )     (9.7 )     (11.2 )

Other expense, net

     (2.5 )     (2.8 )     (5.2 )     (6.1 )
    


 


 


 


Income from continuing operations before income taxes

   $ 17.0     $ 8.7     $ 26.0     $ 8.4  
    


 


 


 


Net income:

                                

Earnings excluding discontinued operations and nonrecurring item

   $ 11.4     $ 5.7     $ 17.2     $ 5.6  

Discontinued operations (c)

     —         —         —         14.8  

Nonrecurring item (a)

     —         —         —         1.6  
    


 


 


 


Net income

   $ 11.4     $ 5.7     $ 17.2     $ 22.0  
    


 


 


 


Basic earnings per share:

                                

Earnings excluding discontinued operations and nonrecurring item

   $ 0.67     $ 0.34     $ 1.02     $ 0.33  

Discontinued operations (c)

     —         —         —         0.89  

Nonrecurring item (a)

     —         —         —         0.10  
    


 


 


 


Net income

   $ 0.67     $ 0.34     $ 1.02     $ 1.32  
    


 


 


 


Diluted earnings per share:

                                

Earnings excluding discontinued operations and nonrecurring item

   $ 0.66     $ 0.34     $ 1.00     $ 0.33  

Discontinued operations (c)

     —         —         —         0.88  

Nonrecurring item (a)

     —         —         —         0.10  
    


 


 


 


Net income

   $ 0.66     $ 0.34     $ 1.00     $ 1.31  
    


 


 


 



Notes to Segment Results and Other Financial Information

 

Prior periods have been reclassified to conform to the current presentation.

 

(a) The nonrecurring item after income taxes amounts to $1.6 million and results from the 2003 gain on the implementation of Statement of Financial Accounting Standards (SFAS) No. 143. This nonrecurring item is included in segment operating profit.
(b) For segment reporting, the 2003 gain on the implementation of SFAS No. 143 is shown in operating profit as a nonrecurring item. In the Consolidated Statements of Income, this item is shown as a cumulative effect of accounting change.
(c) Discontinued operations reflect the gain ($23.2 million before tax) on the disposal of the phenolic antioxidant business, which was sold in January 2003.

 

Attachment 1 of 4


NEWMARKET CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share amounts, unaudited)

 

    

Three Months Ended

June 30


  

Six Months Ended

June 30


 
     2004

   2003

   2004

   2003

 

Net sales

   $ 221,510    $ 180,574    $ 438,280    $ 354,040  

Cost of goods sold

     170,978      136,576      341,887      273,982  
    

  

  

  


Gross profit

     50,532      43,998      96,393      80,058  

TEL marketing agreements services

     10,763      7,931      18,075      10,932  

Selling, general, and administrative expenses

     24,910      21,904      48,428      42,492  

Research, development, and testing expenses

     15,098      15,021      30,847      28,703  
    

  

  

  


Operating profit

     21,287      15,004      35,193      19,795  

Interest and financing expenses

     4,527      6,402      9,683      11,204  

Other income (expense), net

     283      56      449      (142 )
    

  

  

  


Income from continuing operations before income taxes

     17,043      8,658      25,959      8,449  

Income tax expense

     5,689      2,913      8,787      2,841  
    

  

  

  


Income from continuing operations

     11,354      5,745      17,172      5,608  

Discontinued operations (a)

                             

Gain on disposal of business (net of tax)

     —        —        —        14,805  
    

  

  

  


Income before cumulative effect of accounting change

     11,354      5,745      17,172      20,413  

Cumulative effect of accounting change (net of tax) (b)

     —        —        —        1,624  
    

  

  

  


Net income

   $ 11,354    $ 5,745    $ 17,172    $ 22,037  
    

  

  

  


Basic earnings per share:

                             

Earnings from continuing operations

   $ 0.67    $ 0.34    $ 1.02    $ 0.33  

Discontinued operations (net of tax) (a)

     —        —        —        0.89  

Cumulative effect of accounting change (net of tax) (b)

     —        —        —        0.10  
    

  

  

  


     $ 0.67    $ 0.34    $ 1.02    $ 1.32  
    

  

  

  


Diluted earnings per share:

                             

Earnings from continuing operations

   $ 0.66    $ 0.34    $ 1.00    $ 0.33  

Discontinued operations (net of tax) (a)

     —        —        —        0.88  

Cumulative effect of accounting change (net of tax) (b)

     —        —        —        0.10  
    

  

  

  


     $ 0.66    $ 0.34    $ 1.00    $ 1.31  
    

  

  

  


Shares used to compute basic earnings per share

     16,904      16,724      16,859      16,706  
    

  

  

  


Shares used to compute diluted earnings per share

     17,168      16,969      17,144      16,829  
    

  

  

  



Notes to Consolidated Statements of Income

 

(a) Discontinued operations reflect the phenolic antioxidant business, which was sold in January 2003. The gain on the disposal of this business was $23.2 million ($14.8 million after tax or $.89 per share).
(b) The cumulative effect of accounting change for six months 2003 reflects the gain of $2.5 million ($1.6 million after tax or $.10 per share) recognized upon the adoption of Statement of Financial Accounting Standard (SFAS) No. 143 on January 1, 2003.

 

Attachment 2 of 4


NEWMARKET CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     June 30
2004
(unaudited)


    December 31
2003


 
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 21,958     $ 29,052  

Restricted cash

     1,715       1,903  

Trade and other accounts receivable, less allowance for doubtful accounts ($3,316 - 2004; $2,382 - 2003)

     146,067       132,542  

Receivable - TEL marketing agreements services

     2,006       2,456  

Inventories

     128,147       124,428  

Prepaid expenses

     7,417       3,810  

Deferred income taxes

     10,719       11,296  
    


 


Total current assets

     318,029       305,487  
    


 


Property, plant and equipment, at cost

     754,280       751,919  

Less accumulated depreciation and amortization

     588,859       577,686  
    


 


Net property, plant and equipment

     165,421       174,233  
    


 


Prepaid pension cost

     21,858       21,829  

Deferred income taxes

     6,770       5,471  

Other assets and deferred charges

     72,996       75,564  

Intangibles, net of amortization

     59,613       62,849  
    


 


Total assets

   $ 644,687     $ 645,433  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 56,392     $ 53,589  

Accrued expenses

     40,487       50,691  

Long-term debt, current portion

     582       6,978  

Income taxes payable

     9,092       10,055  
    


 


Total current liabilities

     106,553       121,313  
    


 


Long-term debt

     204,147       201,839  

Other noncurrent liabilities

     118,476       122,598  

Shareholders’ equity

                

Common stock ($1 par value)

                

Issued - 16,963,759 in 2004 and 16,786,009 in 2003

     16,964       16,786  

Additional paid in capital

     67,686       67,091  

Accumulated other comprehensive loss

     (22,281 )     (20,164 )

Retained earnings

     153,142       135,970  
    


 


       215,511       199,683  
    


 


Total liabilities and shareholders’ equity

   $ 644,687     $ 645,433  
    


 


 

Attachment 3 of 4


NEWMARKET CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 

    

Six Months Ended

June 30


 
     2004

    2003

 

Cash and cash equivalents at beginning of year

   $ 29,052     $ 15,478  
    


 


Cash flows from operating activities:

                

Net income

     17,172       22,037  

Adjustments to reconcile net income to cash flows from operating activities:

                

Depreciation and amortization

     21,682       23,285  

Amortization of deferred financing costs

     1,636       3,228  

Cumulative effect of accounting changes

     —         (2,549 )

Gain on sale of phenolic antioxidant business

     —         (23,196 )

Noncash pension expense

     5,158       4,633  

Deferred income tax (benefit) expense

     (2,169 )     118  

Working capital changes

     (31,457 )     (6,071 )

Cash pension contributions

     (7,022 )     (3,135 )

TEL working capital advance

     114       1,300  

Proceeds from legal settlement

     —         4,825  

Other, net

     614       (82 )
    


 


Cash provided from operating activities

     5,728       24,393  
    


 


Cash flows from investing activities:

                

Capital expenditures

     (6,047 )     (4,104 )

Proceeds from sale of phenolic antioxidant business

     —         27,770  

Proceeds from sale of certain assets

     —         12,576  

Prepayment for TEL marketing agreements services

     —         (3,200 )

Other, net

     11       13  
    


 


Cash (used in) provided from investing activities

     (6,036 )     33,055  
    


 


Cash flows from financing activities:

                

Repayment of term loan

     (53,807 )     (14,490 )

Repayment of debt - previous agreements

     —         (284,519 )

Issuance of revolving credit agreement

     50,000       —    

Issuance of senior notes and term loan

     —         265,000  

Debt issuance costs

     (1,089 )     (13,094 )

Proceeds from exercise of stock options

     773       195  

Other, net

     (281 )     (239 )
    


 


Cash used in financing activities

     (4,404 )     (47,147 )
    


 


Effect of foreign exchange on cash and cash equivalents

     (2,382 )     1,077  
    


 


(Decrease) increase in cash and cash equivalents

     (7,094 )     11,378  
    


 


Cash and cash equivalents at end of period

   $ 21,958     $ 26,856  
    


 


 

Attachment 4 of 4